(Q43604235)

English

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

steatohepatitis

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Guruprasad P. Aithal

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

object named as

Indra N Guha

3

0 references

William Rosenberg

object named as

William M Rosenberg

10

0 references

author name string

Sudeep Tanwar

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Paul M Trembling

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Julie Parkes

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Philip Kaye

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Stephen D Ryder

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Christopher P Day

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

103-111

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Pathology of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Hyaluronan and its catabolic products in tissue injury and repair

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Nonalcoholic steatohepatitis: pathologic features and differential diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

21 January 2018

Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

7 January 2021

based on heuristic

inferred from DOI database lookup

An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26030

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26030

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

release_zrbqzio5fra7rhniemr6dhh7vm

1 reference

https://api.fatcat.wiki/v0/release/zrbqzio5fra7rhniemr6dhh7vm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604235&oldid=2101847646"